ABBVIE INC. vs. Arcturus Therapeutics Holdings Inc. Common Stock
ABBV
ABBVIE INC.
$256.42 +0.37%
VS ARCTArcturus Therapeutics Holdings Inc. Common Stock
$14.46 -4.77%
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABBV | ARCT | |
|---|---|---|
| Market Cap | $451.46 billion | $431.75 million |
| Revenue (TTM) | $64.39 billion | $29.37 million |
| Net Income (TTM) | $6.32 billion | $-93,276,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | ARCT | |
|---|---|---|
| P/E Ratio | 72.44 | — |
| Price / Book | -76.68 | 2.51 |
| Price / Sales | 7.01 | 14.70 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | ARCT | |
|---|---|---|
| Net Margin | 9.81% | -317.62% |
| Return on Equity | -107.29% | -54.29% |
ABBV and ARCT split the profitability factors evenly.
Dividend
| ABBV | ARCT | |
|---|---|---|
| Dividend Yield | 2.70% | — |
| Payout Ratio | 195.48 | — |
ABBV and ARCT split the dividend factors evenly.
Risk & Sentiment
| ABBV | ARCT | |
|---|---|---|
| Short Interest | 0.85% | 0.22% |
ARCT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, ARCT overview, ARCT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.